GILEAD SCIENCES, LDA secures contract for Antineoplastic and immunomodulating agents - 2023/0481 - Axicabtagene ciloleucel [04 - 2 x10e8 cells; Inj dispersion; BAG]

Posted On: 2025-11-04

Portugal, Nov. 4 -- Portugal based GILEAD SCIENCES, LDA has secured contract from Unidade Local de Saude Santa Maria, E.P.E. for Antineoplastic and immunomodulating agents - 2023/0481 - Axicabtagene ciloleucel [04 - 2 x10e8 cells; Inj dispersion; BAG]. The value of the contract is worth 29629797 EUR.

Published by HT Digital Content Services with permission from Pivotal Sources....

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

GILEAD SCIENCES, LDA secures contract for Antineoplastic and immunomodulating agents - 2023/0481 - Axicabtagene ciloleucel [04 - 2 x10e8 cells; Inj dispersion; BAG]